Garfield Greg Shaw 4
4 · NeuroPace Inc · Filed Apr 23, 2021
Insider Transaction Report
Form 4
NeuroPace IncNPCE
Garfield Greg Shaw
Director
Transactions
- Award
Stock Option (Right to Buy)
2021-04-21+21,698→ 21,698 totalExercise: $17.00Exp: 2031-04-20→ Common Stock (21,698 underlying) - Purchase
Common Stock
2021-04-21$17.00/sh+13,235$224,995→ 38,853 total
Footnotes (2)
- [F1]Reflects shares purchased from the underwriters in the Companys initial public offering.
- [F2]1/36th of the shares subject to the option vest in equal monthly installments commencing May 21, 2021.